Details of Drug-Drug Interaction
| Drug General Information (ID: DDIUTD9Q1N) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Amiloride | Drug Info | Tetracosactide | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Diuretics | Diagnostic Agents | |||||||
| Structure | |||||||||
| Mechanism of Amiloride-Tetracosactide Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antagonize the effect of antihypertensive agents Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Amiloride | Tetracosactide | |||||||
| Mechanism | Antihypertensive agent |
Hypertensive effects Induction of sodium and fluid retention |
|||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Antihypertensive agents | ||||||||
| Factor Description | The hypotensive effect of antihypertensive agents may be reduced, leading to higher blood pressure, increased blood pressure fluctuations, and possible cardiovascular damage. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Patients on prolonged (i.e., longer than about a week) or high-dose corticosteroid therapy should have blood pressure, electrolyte levels, and body weight monitored regularly, and be observed for the development of edema and congestive heart failure. The dosages of antihypertensive medications may require adjustment. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cerner Multum, Inc. "UK Summary of Product Characteristics.". | ||||||||||||||||||
| 2 | Multum Information Services, Inc. Expert Review Panel. | ||||||||||||||||||

